Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

| More on:
A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Many of Australia's top brokers have been busy adjusting their financial models again. This has led to the release of a number of broker notes this week.

Three ASX shares that brokers have named as buys this week are listed below. Here's why they are feeling bullish on them right now:

Hub24 Ltd (ASX: HUB)

According to a note out of Morgan Stanley, its analysts have retained their overweight rating and $44.00 price target on this investment platform provider's shares. This follows the release of the company's third-quarter update this week. Morgan Stanley highlights that the company's platform funds under administration (FUA) of $79.7 billion came in ahead of its estimates. In light of this and higher seasonal flows, the broker sees scope for the company to outperform in the fourth quarter. The broker was also pleased to see management reaffirm its guidance for platform FUA to reach $92 billion to 100 billion in FY 2025. The HUB24 share price is trading at $39.62 this afternoon.

Pro Medicus Limited (ASX: PME)

A note out of Goldman Sachs reveals that its analysts have initiated coverage on this health imaging company's shares with a buy rating and $134.00 price target. The broker sees Pro Medicus as the clear incumbent technology leader in a growing market with a strong financial profile and significant artificial intelligence upside. Goldman believes that the company's Visage 7 platform is core to many healthcare institutions, providing efficiency gains in a market where demand for imaging continues to grow and radiologist shortages persist. It thinks it can increase its US market share to 13% in FY 2030 from ~7% today. The Pro Medicus share price is fetching $101.94 on Wednesday.

Zip Co Ltd (ASX: ZIP)

Analysts at UBS have retained their buy rating on this buy now pay later provider's shares with an improved price target of $1.55. This follows the release of the company's third-quarter update this week which revealed a 14.6% increase in total transaction volume and a 26.6% jump in revenue. UBS was pleased with the stronger-than-expected update. It notes that it was driven by a particularly strong performance from its Zip Americas business. And while it was slightly disappointed with the performance of the Zip AU business, it believes this will stabilise in FY 2025 and then return to growth. Overall, the broker was impressed and its earnings estimates have been revised higher. The Zip share price is trading at $1.14 on Wednesday afternoon.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Hub24, Pro Medicus, and Zip Co. The Motley Fool Australia has recommended Hub24 and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

These ASX shares could rise 20% to 40%

Big returns could be on offer from these stocks according to analysts.

Read more »

Two parents and two children happily eat pizza in their kitchen as a top broker predicts a 46% upside for the Domino's share price
Broker Notes

Buy one, sell the other: Goldman's take on these 2 ASX retail shares

Despite high interest rates and inflation, ASX retail shares have been on a strong run.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Woman and man calculating a dividend yield.
Bank Shares

Is the Macquarie share price worth $200 after its FY25 update?

Here’s a top broker’s view on the global investment bank.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Broker Notes

How I'd invest $5,000 in ASX shares right now

Analysts think these buy-rated stocks could be great options for those funds.

Read more »

A female stockbroker reviews share price performance in her office with the city shown in the background through her windows
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Miner looking at a tablet.
Broker Notes

Should you buy the dip on South32 shares?

Could the sell-off be a buying opportunity?

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Broker Notes

Why did this top broker just downgrade DroneShield shares?

The broker believes its shares are fully valued at current levels.

Read more »